The Russian State Research Center of Virology and Biotechnology Vector has started developing a new Coronavirus (COVID-19) vaccine in the form of nasal drops, an official said.
Vector General Director Rinat Maksyutov said in an interview with Sputnik that the vaccine would help provide immunity right at the “entrance gate” of the infection, “Yes, we have started developing a vaccine in the form of drops, an intranasal vaccine.
READ ALSO Putin Reveals Why He Won't Be Taking Russia's COVID-19 Vaccine
“The composition of the main active component of the vaccine will remain unchanged (same as that of the EpiVacCorona vaccine),” Maksyutov said.
READ ALSO Russia's Coronavirus Vaccine Shows Success In Early Trials
The vaccine will help develop immunity in the nasal mucous membranes, which can be described as the “entrance gate” of the infection, Maksyutov specified.
0 Comment(s)